Activity of ceftaroline-avibactam tested against contemporary enterobacteriaceae isolates carrying β-lactamases prevalent in the United States

Microbial Drug Resistance

Volumn 20, Issue 5, 2014, Pages 436-440

  Castanheira, Mariana ^a   Williams, Gregory ^b   Jones, Ronald N ^a   Sader, Helio S ^a  

^a JMI LABORATORIES   (United States)

^b Cerexa Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AVIBACTAM; BETA LACTAMASE CTX M; CARBAPENEMASE; CEFTAROLINE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PENICILLINASE; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; AZABICYCLO DERIVATIVE; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; DRUG COMBINATION;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; UNITED STATES; CLASSIFICATION; DRUG COMBINATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG COMBINATIONS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PROTEUS MIRABILIS; UNITED STATES;

EID: 84907473929     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0181     Document Type: Article

References (11)

1. Bogdanovich, T., J.M., Adams-Haduch, G.B., Tian, M.H., Nguyen, E.J., Kwak, C.A., Muto, and Y., Doi. 2011. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin. Infect. Dis. 53:373-376.
2. Castanheira, M., H.S., Sader, D.J., Farrell, R.E., Mendes, and R.N., Jones. 2012. Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types. Antimicrob. Agents Chemother. 56:4779-4785.
3. Castanheira, M., S.E., Farrell, L.M., Deshpande, R.E., Mendes, and R.N., Jones. 2013. Prevalence of b-lactamase encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 USA hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010). Antimicrob. Agents Chemother. 57:3012-3020.
4. [CLSI] Clinical and Laboratory Standards Institute 2012. M07-A9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: ninth edition. Wayne, PA: Clinical and Laboratory Standards Institute.
5. [CLSI] Clinical and Laboratory Standards Institute 2013. M100-S23. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Drawz, S.M., and R.A., Bonomo. 2010. Three decades of beta-lactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
7. Endimiani, A., Y., Choudhary, and R.A., Bonomo. 2009. In vitro activity of NXL104 in combination with b-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Antimicrob. Agents Chemother. 53:3599-3601.
8. EUCAST. 2013. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0, January 2013. Available at www.eucast.org/clinical-breakpoints/. (Accessed January 2, 2013).
9. Riccobene, T.A., S.F., Su, and D., Rank. 2013. Singleand multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects. Antimicrob. Agents Chemother. 57:1496-1504.
10. Spanu, T., G., De Angelis, M., Cipriani, B., Pedruzzi, T., DInzeo, M.A., Cataldo, G., Sganga, and E., Tacconelli. 2012. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 56: 4516-4518.
11. Woodford, N., J.F., Turton, and D.M., Livermore. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.